MICAD SYSTEMS (U.K.) LIMITED

Financial Health Score: B (Stable)

Explanation: Based on the available structural and compliance data, Micad Systems (U.K.) Limited presents as a stable, long-standing enterprise with healthy corporate hygiene. However, like a patient who has yet to undergo a full blood panel, the absence of detailed balance sheet and profit & loss metrics in this specific filing prevents a perfect score. The robust share capital and strong parental backing provide a sturdy immune system against market volatility, though the unusually high number of directors for a "Small" company warrants a closer look at potential administrative overhead.

Key Vital Signs

• Corporate Longevity (Age): 37 years. Incorporating in 1987 indicates a very strong constitution. Surviving multiple economic cycles requires adaptability and resilience—this is a business with a long track record of staying power.
• Compliance Pulse (Filing Status): Strong & Steady. Both the annual accounts and the confirmation statement are up to date, with the next accounts not due until late 2026. There are no symptoms of administrative distress or overdue filings, which is often the first sign of corporate ill health.
• Corporate Bone Density (Share Capital): £100,000. This is a very healthy capital base. It shows that the business has substantial skin in the game and is not running on an empty financial stomach, providing a solid buffer against unexpected liabilities.
• Ownership & Control (PSC): Young Associates Limited (>75%). With a single corporate entity holding more than 75% of the shares, the company benefits from decisive governance. There is no risk of ownership paralysis; however, it does mean the company's financial health is intrinsically linked to the wellness of its parent entity.
• Organizational White Blood Cell Count (Directorate): 8 Directors. For a company classified as "Small," having eight directors is unusually high. This could indicate a robust, multi-disciplinary leadership team providing excellent oversight, but it could also point to top-heavy administrative costs that may be weighing down the company's metabolic efficiency.

Diagnosis

The structural data reveals a business that is in good compliance health but presents a complex anatomical structure.

Micad Systems operates in the computer facilities management space, specifically digitizing and transforming estates for universities, healthcare, and corporate sectors. These are typically stable, contract-based revenue streams, which acts as a healthy, reliable diet for the business.

The primary symptom requiring observation is the ratio of directors to company size. While the £100,000 share capital provides a strong foundation, an eight-person board for a small enterprise suggests either a highly specialized governance structure or a legacy board. If these directors are drawing significant remuneration, it could be placing pressure on the company's cash flow metabolism.

Furthermore, because the company is wholly subordinate to Young Associates Limited, its financial bloodstream is tied to the parent company. If the parent company experiences financial hypertension (debt stress) or anemia (cash flow shortages), Micad Systems could suffer from restricted nutrient flow (underinvestment), regardless of its own operational health.

Note: A full diagnostic would require reviewing the detailed Profit & Loss reserves and current liabilities—vital signs not included in this specific dataset—to truly assess if the company is running a financial fever (operating at a loss) or enjoying healthy cash flow.

Recommendations

1. Conduct a Full Financial Blood Panel: As a "Small" company, Micad Systems files abbreviated accounts, which hides the detailed P&L and balance sheet metrics from public view. Internal stakeholders must regularly review the full, unabbreviated accounts to monitor working capital (Net Current Assets) and ensure the business isn't suffering from hidden liquidity anemia.
2. Review Board Efficiency (Director Diet): Evaluate the necessity and contribution of all eight directors. Ensure that the administrative and remuneration costs associated with such a large board are proportionate to the company's turnover, preventing unnecessary drag on profitability.
3. Monitor Parent Health: Regularly assess the financial wellness of Young Associates Limited. Because they own more than 75% of the business, any financial contagion from the parent company could easily spread to Micad Systems. Ensure inter-company loans or transactions are conducted at arm's length and do not drain the subsidiary's cash reserves.
4. Leverage Market Position: Operating in the healthcare and university estates digitization space offers long-term contract stability. The company should continue to invest in its technological "immune system"—updating software and cybersecurity—to maintain its competitive edge and protect its reliable revenue streams.